Literature DB >> 6345584

Mechanisms of insulin resistance in aging.

R I Fink, O G Kolterman, J Griffin, J M Olefsky.   

Abstract

We have studied 17 elderly and 27 non-elderly, nonobese subjects (mean age 69+/-1 and 37+/-2 yr, respectively) to assess the mechanisms responsible for the abnormal carbohydrate tolerance associated with aging. Serum glucose and insulin levels were significantly elevated in the elderly subjects compared with the nonelderly subjects during a 75-g oral glucose tolerance test, suggesting an insulin resistant state. Peripheral insulin sensitivity was assessed in both groups using the euglycemic glucose clamp technique during an insulin infusion rate of 40 mU/m(2) per min. Similar steady-state serum insulin levels led to a peripheral glucose disposal rate of 151+/-17 mg/m(2) per min in the elderly compared with a value of 247+/-12 mg/m(2) per min in the nonelderly, thus documenting the presence of insulin resistance in the elderly subjects. Insulin binding to isolated adipocytes and monocytes was similar in the elderly and nonelderly groups (2.34+/-0.33 vs. 2.62+/-0.24% and 5.04+/-1.10 vs. 5.12+/-1.07%), respectively. Thus, insulin resistance in the presence of normal insulin binding suggests the presence of a postreceptor defect in insulin action. This was confirmed by performing additional euglycemic clamp studies using infusion rates of 15 and 1,200 mU/m(2) per min to assess the contours of the dose-response relationship. These studies revealed a 39 and 25% decrease in the glucose disposal rate in the elderly subjects, respectively. The results confirm the presence of a postreceptor defect as well as a rightward shift in the dose-response curve. Insulin's ability to suppress hepatic glucose output was less in the elderly subjects during the 15 mU/m(2) per min insulin infusion (77+/-5 vs. 89+/-4% suppression), but hepatic glucose output was fully and equally suppressed in both groups during the 40 and 1,200 mU/m(2) per min infusion. Finally, a significant inverse relationship was observed between the degree of glucose intolerance in the individual elderly subjects, as reflected by the 2-h serum glucose level during the oral glucose tolerance test, and the degree of peripheral insulin resistance as assessed by the glucose disposal rate during the 40 mU/m(2) per min insulin infusion (r = 0.59, P < 0.01).We conclude that carbohydrate intolerance develops as part of the aging process. This carbohydrate intolerance appears to be the consequence of peripheral insulin resistance caused by a postreceptor defect in target tissue insulin action, which causes both a decrease in the maximal rate of peripheral glucose disposal and a rightward shift in the insulin action dose-response curve. In elderly subjects, the severity of the abnormality in carbohydrate tolerance is directly correlated to the degree of peripheral insulin resistance.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6345584      PMCID: PMC370358          DOI: 10.1172/jci110908

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  Effects of an oral glucose load on serum immunoreactive insulin, free fatty acid, growth hormone and blood sugar levels in young and elderly subjects.

Authors:  H Sandberg; N Yoshimine; S Maeda; D Symons; J Zavodnick
Journal:  J Am Geriatr Soc       Date:  1973-10       Impact factor: 5.562

2.  Effect of age on corbohydrate metabolism.

Authors:  J B O'Sullivan; C M Mahan; A E Freedlender; R F Williams
Journal:  J Clin Endocrinol Metab       Date:  1971-10       Impact factor: 5.958

3.  Age-related insulin patterns in normal glucose tolerance.

Authors:  S Nolan; T Stephan; S Chae; C Vidalon; C Gegick; R C Khurana; T S Danowski
Journal:  J Am Geriatr Soc       Date:  1973-03       Impact factor: 5.562

4.  Carbohydrate tolerance in the very aged.

Authors:  M J Smith; M R Hall
Journal:  Diabetologia       Date:  1973-10       Impact factor: 10.122

Review 5.  Quantification of fat, muscle and bone in man.

Authors:  R M Malina
Journal:  Clin Orthop Relat Res       Date:  1969 Jul-Aug       Impact factor: 4.176

6.  Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays.

Authors:  B Desbuquois; G D Aurbach
Journal:  J Clin Endocrinol Metab       Date:  1971-11       Impact factor: 5.958

7.  Effects of oral chromium supplementation on the glucose tolerance of elderly human subjects.

Authors:  R A Levine; D H Streeten; R J Doisy
Journal:  Metabolism       Date:  1968-02       Impact factor: 8.694

8.  The pancreatic beta-cell response to intravenous administration of glucose in elderly subjects.

Authors:  G Barbagallo-Sangiorgi; E Laudicina; G D Bompiani; F Durante
Journal:  J Am Geriatr Soc       Date:  1970-07       Impact factor: 5.562

9.  Chromium deficiency as a factor in atherosclerosis.

Authors:  H A Schroeder; A P Nason; I H Tipton
Journal:  J Chronic Dis       Date:  1970-08

10.  Glucose tolerance, plasma insulin, and free fatty acids in elderly subjects.

Authors:  R Metz; B Surmaczynska; S Berger; G Sobel
Journal:  Ann Intern Med       Date:  1966-05       Impact factor: 25.391

View more
  121 in total

1.  Acute heat treatment improves insulin-stimulated glucose uptake in aged skeletal muscle.

Authors:  Anisha A Gupte; Gregory L Bomhoff; Chad D Touchberry; Paige C Geiger
Journal:  J Appl Physiol (1985)       Date:  2010-12-09

2.  Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance.

Authors:  Ewan C McNay; Cecilia T Ong; Rory J McCrimmon; James Cresswell; Jonathan S Bogan; Robert S Sherwin
Journal:  Neurobiol Learn Mem       Date:  2010-02-20       Impact factor: 2.877

3.  Age-related memory impairments due to reduced blood glucose responses to epinephrine.

Authors:  Ken A Morris; Qing Chang; Eric G Mohler; Paul E Gold
Journal:  Neurobiol Aging       Date:  2009-01-28       Impact factor: 4.673

Review 4.  Pathogenesis of impaired glucose tolerance and type II diabetes mellitus--current status.

Authors:  M B Davidson
Journal:  West J Med       Date:  1985-02

5.  Insulin resistance syndrome as a feature of cardiological syndrome X in non-obese men.

Authors:  J W Swan; C Walton; I F Godsland; D Crook; M F Oliver; J C Stevenson
Journal:  Br Heart J       Date:  1994-01

Review 6.  Drug dosage in the elderly. Is it rational?

Authors:  K Turnheim
Journal:  Drugs Aging       Date:  1998-11       Impact factor: 3.923

Review 7.  Sirtuins and NAD+ in the Development and Treatment of Metabolic and Cardiovascular Diseases.

Authors:  Alice E Kane; David A Sinclair
Journal:  Circ Res       Date:  2018-09-14       Impact factor: 17.367

Review 8.  Age-Related Changes in Glucose Metabolism, Hyperglycemia, and Cardiovascular Risk.

Authors:  Chee W Chia; Josephine M Egan; Luigi Ferrucci
Journal:  Circ Res       Date:  2018-09-14       Impact factor: 17.367

9.  Interrelation between plasma testosterone and plasma insulin in healthy adult men: the Telecom Study.

Authors:  D Simon; P Preziosi; E Barrett-Connor; M Roger; M Saint-Paul; K Nahoul; L Papoz
Journal:  Diabetologia       Date:  1992-02       Impact factor: 10.122

10.  Hypomagnesaemia in type 2 (non-insulin-dependent) diabetes mellitus is not corrected by improvement of long-term metabolic control.

Authors:  C Schnack; I Bauer; P Pregant; P Hopmeier; G Schernthaner
Journal:  Diabetologia       Date:  1992-01       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.